Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Curr Drug Metab. 2010 Oct;11(8):693–714. doi: 10.2174/138920010794233477

Table 3.

US FDA-Approved Estrogen and Estrogen-Progestin Preparations for MHT

Route of Administration Estrogenic Compound Commercial Name

Oral Estradiol - drospirenone Angeliq® Tablets

Synthetic conjugated estrogens EnjuviaTM

Norethindrone acetate/ethinyl estradiol FemHRT

Estradiol/norgestimate PrefestTM

CEE Premarin®

CEE/MPA PremproTM

Transdermal Patches Estradiol Alora®
Estraderm®
Menostar®
Vivelle®, Vivelle-Dot®

Estradiol/Levonorgestrel Climara ProTM

Estradiol/Norethindrone acetate CombiPatch®

Injection Estradiol valerate Delestrogen®

CEE Premarin®

Topical Emulsion Estradiol EstrasorbTM

Vaginal Estradiol acetate Femring®

CEE Premarin®
HHS Vulnerability Disclosure